Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
EXSCIENTIA PLC |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 5.58 USD | -4.12% | -9.56% | +4.69% | |
| Nov. 09 | Transcript : Exscientia plc, Q3 2023 Earnings Call, Nov 09, 2023 | CI |
| Nov. 09 | Exscientia plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| Sales 2023 * | 29.73M 37.3M | Sales 2024 * | 60.28M 75.63M | Capitalization | 578M 726M |
|---|---|---|---|---|---|
| Net income 2023 * | -149M -187M | Net income 2024 * | -163M -204M | EV / Sales 2023 * | 17,3x |
| Net cash position 2023 * | 65.24M 81.85M | Net cash position 2024 * | 142M 179M | EV / Sales 2024 * | 7,23x |
| P/E ratio 2023 * | -4,27x | P/E ratio 2024 * | -3,82x | Employees | 481 |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 73.1% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -4.12% | ||
| 1 week | -9.56% | ||
| Current month | -8.52% | ||
| 1 month | +0.54% | ||
| 3 months | +1.45% | ||
| 6 months | -32.28% | ||
| Current year | +4.69% |
1 week
5.38
6.61
1 month
4.956.61
Current year
4.1711.52
1 year
4.0911.52
3 years
4.0930.38
5 years
4.0930.38
10 years
4.0930.38
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 51 | 2011 | |
Ben R. Taylor
DFI | Director of Finance/CFO | 45 | 2020 |
David Hallett
CTO | Chief Tech/Sci/R&D Officer | 53 | 2020 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mario Polywka
BRD | Director/Board Member | 60 | 2017 |
| Chairman | 67 | 2020 | |
Elizabeth Crain
BRD | Director/Board Member | 58 | 2021 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.03% | 10 M€ | -14.65% | ||
| 0.87% | 8 M€ | -14.99% | ||
| 0.05% | 6,059 M€ | -5.64% | ||
| 0.05% | 284 M€ | +22.46% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-08 | 5.58 | -4.12% | 819 361 |
| 23-12-07 | 5.82 | -8.06% | 507,475 |
| 23-12-06 | 6.33 | +2.26% | 876,774 |
| 23-12-05 | 6.19 | +0.16% | 175,942 |
| 23-12-04 | 6.18 | +0.16% | 413,227 |
Delayed Quote Nasdaq, December 08, 2023 at 04:00 pm EST
More quotes
Exscientia PLC is a United Kingdom-based intelligence-driven (AI) precision medicine company. The Company is focused on discovering, designing and developing the possible drugs. The Company has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its precision medicine platform in oncology, while its partnered pipeline broadens its approach to other therapeutic areas. Its patient-first AI includes Precision Target, Precision Design, Precision Experiment, Precision Medicine, Presentations and Publications. Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. Its advanced biophysical and x-ray techniques provide the ideal experimental underpinnings for AI-design.
Calendar
2024-03-19
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.629GBP
Average target price
7.761GBP
Spread / Average Target
+67.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.69% | 727 M $ | |
| +70.40% | 41 191 M $ | |
| +5.07% | 39 236 M $ | |
| -55.28% | 30 484 M $ | |
| -27.34% | 27 837 M $ | |
| -28.45% | 22 245 M $ | |
| +40.26% | 22 079 M $ | |
| +4.49% | 16 633 M $ | |
| -13.10% | 11 376 M $ | |
| -17.58% | 10 762 M $ |
